Back to Search
ROBYN ZEHR, D.O.
D.O.
Family Medicine Physician
NPI: 1689835365Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
49305(CO)
Research & Publications (14)
Gene expression profiling in the liver and lung of perfluorooctane sulfonate-exposed mouse fetuses: comparison to changes induced by exposure to perfluorooctanoic acid.
PMID 19429403·Reprod Toxicol·2009
4-observational
Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse.
PMID 18595657·Reprod Toxicol·2009
7-preclinical
Modeling single and repeated dose pharmacokinetics of PFOA in mice.
PMID 19005225·Toxicol Sci·2009
7-preclinical
Effects of perfluorobutyrate exposure during pregnancy in the mouse.
PMID 18511431·Toxicol Sci·2008
7-preclinical
Comparative hepatic effects of perfluorooctanoic acid and WY 14,643 in PPAR-alpha knockout and wild-type mice.
PMID 18467680·Toxicol Pathol·2008
4-observational
Gene profiling in the livers of wild-type and PPARalpha-null mice exposed to perfluorooctanoic acid.
PMID 18467677·Toxicol Pathol·2008
7-preclinical
Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses.
PMID 17681415·Toxicology·2007
7-preclinical
Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha.
PMID 17488742·Toxicol Sci·2007
7-preclinical
The cyanobacterial toxin, cylindrospermopsin, induces fetal toxicity in the mouse after exposure late in gestation.
PMID 17292934·Toxicon·2007
7-preclinical
Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring.
PMID 17132714·Toxicol Sci·2007
7-preclinical
Abductor reattachment with a custom proximal femoral replacement prosthesis.
PMID 12138957·Orthopedics·2002
8-other
Phase II trial of liposomal doxorubicin (Doxil) in advanced soft tissue sarcomas.
PMID 10958594·Invest New Drugs·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 555 PROSPECT AVE, SUITE 300
ESTES PARK, CO 80517 - Phone
- (970) 586-2200
Quick Facts
- NPI
- 1689835365
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile